Procter & Gamble (PG) shares extended gains on Aug. 4 after the company announced a definitive agreement to acquire premium wellness and dietary supplement maker Thorne. The $3.8 billion all-cash transaction equips the NYSE-listed consumer staple giant with immediate scale in the rapidly expanding health and self-care market.
Despite recent gains, Procter & Gamble stock is down roughly 12% versus its year-to-date high in late February.